These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 26965352)

  • 1. The clinical relevance of treatment with antidepressants.
    Nolen WA
    Acta Neuropsychiatr; 1995 Jun; 7(2):52-4. PubMed ID: 26965352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression.
    Lotufo-Neto F; Trivedi M; Thase ME
    Neuropsychopharmacology; 1999 Mar; 20(3):226-47. PubMed ID: 10063483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing antidepression overdoses.
    Miller J
    Emerg Med Serv; 2004 Oct; 33(10):113-9. PubMed ID: 15553532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D; Silver JM; Opler LA
    J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the horizons of depression: beyond the monoamine hypothesis.
    Hindmarch I
    Hum Psychopharmacol; 2001 Apr; 16(3):203-218. PubMed ID: 12404573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy reviews: tricyclic antidepressant and monoamine oxidase inhibitor combination therapy.
    Ponto LB; Perry PJ; Liskow BI; Seaba HH
    Am J Hosp Pharm; 1977 Sep; 34(9):954-61. PubMed ID: 333909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants.
    Anderson IM; Tomenson BM
    J Psychopharmacol; 1994 Jan; 8(4):238-49. PubMed ID: 22298630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in antidepressant drugs.
    Priest RG; Baldwin DS; Bullock T; Kibel D; Smeyatsky N; Steinert J
    S Afr Med J; 1992 Jun; Suppl():1-4. PubMed ID: 1609337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy in long-term treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in and Preventive Effects for Oral-Cancer Risk with Antidepressant Treatment.
    Chung CM; Kuo TM; Yeh KT; Lee CH; Ko YC
    J Pers Med; 2021 Jun; 11(7):. PubMed ID: 34201475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Widespread hypothalamic-pituitary-adrenocortical axis-relevant and mood-relevant effects of chronic fluoxetine treatment on glucocorticoid receptor gene expression in mice.
    Heydendael W; Jacobson L
    Eur J Neurosci; 2010 Mar; 31(5):892-902. PubMed ID: 20374287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The tolerability and efficacy of combined antidepressant therapy: literature review].
    Taleb M; Gorwood P; Bouleau JH; Rouillon F
    Encephale; 1996; 22(6):450-60. PubMed ID: 10901838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do SSRIs prolong seizure duration during ECT?
    Potokar J; Wilson S; Nutt DJ
    Int J Psychiatry Clin Pract; 1997; 1(4):277-80. PubMed ID: 24946194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase inhibitors: reversible and irreversible.
    Rudorfer MV
    Psychopharmacol Bull; 1992; 28(1):45-57. PubMed ID: 1609042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive efficacy of antidepressants: assessment of five antidepressants and four monoamine receptors in rats.
    Otsuka N; Kiuchi Y; Yokogawa F; Masuda Y; Oguchi K; Hosoyamada A
    J Anesth; 2001; 15(3):154-8. PubMed ID: 14566514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of serendipity in the discovery of classical antidepressant drugs: Applying operational criteria and patterns of discovery.
    López-Muñoz F; D'Ocón P; Romero A; Guerra JA; Álamo C
    World J Psychiatry; 2022 Apr; 12(4):588-602. PubMed ID: 35582332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase inhibitor usage in Hawaii.
    Takeshita J; Goebert D; Huh J; Lu B; Thompson D; Muramatsu R
    Asian J Psychiatr; 2010 Dec; 3(4):213-5. PubMed ID: 23050890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.